Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

British equities slip on higher yields, financials drag

Tue, 02nd Jan 2024 17:05

FTSE 100 down 0.2%, FTSE 250 off 0.9%

*

Marks and Spencer rises on ratings upgrade

*

AstraZeneca up as RSV infant shots approved in China

*

UK factory revival prospects suffer setback in Dec

Jan 2 (Reuters) - London stocks started the year on a sombre note, weighed down by losses in the financial sector and as UK government bond yields climbed to two-weeks high.

The blue-chip FTSE 100 fell 0.2% on Tuesday, after hitting an over seven-month high earlier in the session, while the mid-cap FTSE 250 index was down 0.9%.

Yields on the benchmark 10-year government bond rose over 15 basis points to 3.695%, touching a more than two-week high, tracking moves in U.S. Treasuries as investors moved away from higher risk assets.

The investment banking and brokerage services index led the losses with a 2.2% fall, closely followed by a 1.9% decline in life insurance stocks.

Meanwhile, the FTSE 100 completed its 40th trading year.

"The headline index has made almost no progress since the start of the century, and in the last decade the Footsie has been totally eclipsed by the U.S. stock market," said Laith Khalaf, head of investment analysis at AJ Bell.

Top performer pharma and biotech shares jumped 1.7%, supported by a 1.8% rise in AstraZeneca after the drugmaker's respiratory syncytial virus (RSV) immunisation for infants developed with Sanofi got approval in China.

Oil and gas shares added 0.4% as crude prices moved higher on the prospect of Middle Eastern supply disruptions after a naval clash in the Red Sea.

"Fundamentally, while supply continues to outstrip demand, the escalating hostilities in the Red Sea are raising concerns and providing support," said David Morrison, senior market analyst at Trade Nation.

Among individual movers, Marks and Spencer advanced 1.3% after Exane BNP Paribas raised the retailer's stock rating to "outperform" from "neutral".

Britain's manufacturing sector suffered a setback in its recovery efforts as output and employment fell more sharply in December than in the previous month, according to a survey.

Another set of data showed prices charged by British store chains rose at the slowest pace in a year and a half in December, an industry group said. (Reporting by Khushi Singh, Shubham Batra and Shashwat Chauhan in Bengaluru; Editing by Shinjini Ganguli and Mark Potter)

Related Shares

More News
20 Jun 2024 10:56

TOP NEWS: AstraZeneca's Truqap gets OK from EU for breast cancer form

(Alliance News) - AstraZeneca PLC on Thursday said that the EU approved its prescription medicine Truqap, in combination with hormonal therapy Faslode...

18 Jun 2024 09:33

TOP NEWS: AstraZeneca disappointed by breast cancer drug trial results

(Alliance News) - AstraZeneca PLC on Tuesday said findings from a breast cancer drug trial showed that Truqap did not meet its primary endpoints.

18 Jun 2024 07:51

LONDON BRIEFING: Ashtead profit declines; Whitbread sales rise

(Alliance News) - London's FTSE 100 is called to open higher on Tuesday, taking confidence from a decent showing for US equities overnight, with infla...

18 Jun 2024 07:17

AstraZeneca trial fails to treat 'challenging' breast cancer

(Sharecast News) - AstraZeneca announced on Tuesday that the phase three 'CAPItello-290' trial for 'Truqap', or capivasertib, in combination with pacl...

17 Jun 2024 09:09

TOP NEWS: Astra's Imfinzi plus chemo approved for cancer form in US

(Alliance News) - AstraZeneca PLC on Monday said it secured a new US approval for cancer treatment Imfinzi, also known as durvalumab, hailing an "impo...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.